Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q1 2024 Earnings Presentation
13 slides from Nolato Ab Class B's earnings presentation, Mar 6, 2024
Slide 1: First quarter
First quarter CEO Christer Wahlquist CFO Per-Ola Holmström May 6, 2024 1
Slide 2: Q1 summary – Nolato Group
Q1 summary – Nolato Group A global solutions provider established on three continents ● Sales totaled SEK 2,442 million (2,476) SEKm - A decrease of 2% adjusted for currency and acquisitions 12000 - Growth for Medical Solutions, while Engineered 11000 Solutions saw lower sales 10000 ● Operating prof
Slide 3: One Group – two business areas
One Group – two business areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for selected Development and manufacture of complex Design, development, industrialization and global customers comprises development and product systems and components for medical manufa
Slide 4: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 3000 1,355 140 2500 2000 SALES EBITA-RESULT SEKm, Q1 SEKm, Q1 1500 55 10.3 1000 500 SHARE OF THE GROUP EBITA-MARGIN 0 %, Q1 %, Q1 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 R12M 4 4
Slide 5: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug Delivery In-vitro-diagnostics (IVD) Endoscopy & General Surgery Cardiology Continence care Pharma Packaging Other 5
Slide 6: Medical Solutions – Q1
Medical Solutions – Q1 ● Stable volume situation across most market areas Q1 Full year - Adjusted for currency, an increase of 2 percent. SEKm 2024 2023 2023 2022 - IVD grew compared with a weak quarter last year - Lower volumes in the Other category (customer product recall) - Drug Delivery and Sur
Slide 7: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 4000 1,087 103 3500 3000 2500 SALES EBITA-RESULT SEKm, Q1 SEKm, Q1 2000 1500 45 9.5 1000 500 SHARE OF THE GROUP EBITA-MARGIN 0 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 2
Slide 8: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer electronics Automotive Other Hygiene 8
Slide 9: Engineered Solutions – Q1
Engineered Solutions – Q1 ● 6% decrease in sales Q1 Full year - A decrease of 7% adjusted for currency and acquisitions SEKm 2024 2023 2023 2022 - Consumer Electronics volumes saw a decline in this quarter as well (low volumes from a previously significant customer) Sales 1,087 1,153 4,245 5,922 - A
Slide 10: Key performance indicators Group
Full Q1 Q1 year SEKm 2024 2023 R12M 2023 Net sales 2,442 2,476 9,512 9,546 Operating profit (EBITA)* 238 193 746 701 Adjusted operating profit (EBITA), excl. non-recurring items in 2023 238 193 806 761 Adjusted EBITA margin (%), excl. non-recurring items in 2023 9.7 7.8 8.5 8.0 Profit after financia
Slide 11: Change in Group structure from January 1, 2024
Change in Group structure from January 1, 2024 • Merger of the business areas Medical Solutions Engineered Solutions Integrated Solutions and Industrial Solutions to form Engineered Solutions. • Creates a global offering for new larger customers as well as within the current customer base. • Establi
Slide 12: Current situation
Current situation Medical Solutions Engineered Solutions • Maintained growth strategy • Advanced market positions • Focus on margin – cost adjustments, pricing strategy • Established position in new product areas and efficiency • Focus on innovative and sustainable solutions • Innovation and sustain
Slide 13: www.nolato.com – forward-looking statements
w w w. n o l a t o . c o m This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncert